169 related articles for article (PubMed ID: 15870490)
1. A case of pure red cell aplasia complicated with diffuse large B cell lymphoma, T-cell-rich/histiocyte-rich variant: effectiveness of rituximab and implications for a common immunopathogenic role of B lymphocytes.
Oyaizu N; Kozai Y; Kodo H; Sunaga S; Iwabuchi K; Higashihara M; Mori S
Acta Haematol; 2005; 113(3):194-7. PubMed ID: 15870490
[TBL] [Abstract][Full Text] [Related]
2. [Pure red cell aplasia successfully treated with rituximab in a patient with relapsed diffuse large B-cell lymphoma].
Suzuki T; Kumagai T; Kitano A; Kubo H; Tabata M; Kimura Y; Miura O; Imai Y
Rinsho Ketsueki; 2007 Jan; 48(1):67-70. PubMed ID: 17313080
[TBL] [Abstract][Full Text] [Related]
3. CD5+ T-cell/histiocyte-rich large B-cell lymphoma.
Chang CC; Bunyi-Teopengco E; Eshoa C; Chitambar CR; Kampalath B
Mod Pathol; 2002 Oct; 15(10):1051-7. PubMed ID: 12379751
[TBL] [Abstract][Full Text] [Related]
4. [Primary diffuse large B-cell lymphoma of the bone marrow complicated with autoimmune hemolytic anemia and erythroid hypoplasia].
Sumi M; Ichikawa N; Shimizu I; Yotsumoto M; Ueno M; Kobayashi H
Rinsho Ketsueki; 2007 Jul; 48(7):571-5. PubMed ID: 17695307
[TBL] [Abstract][Full Text] [Related]
5. Anti-erythropoietin receptor antibody-associated pure red cell aplasia accompanied by Coombs-negative autoimmune hemolytic anemia in a patient with T cell/histiocyte-rich large B cell lymphoma.
Fujimi A; Kamihara Y; Kanisawa Y; Hashimoto A; Nakajima C; Hayasaka N; Uemura N; Okuda T; Minami S; Iyama S; Takada K; Sato T; Hara A; Iwata Y; Furuichi K; Wada T; Kato J
Int J Hematol; 2014 Nov; 100(5):490-3. PubMed ID: 25096221
[TBL] [Abstract][Full Text] [Related]
6. Effective in vivo purging with rituximab and autologous peripheral blood stem cell transplantation in a woman with CD5 positive primary cutaneous diffuse large B-cell lymphoma.
Goto H; Nishio M; Endo T; Sato N; Koizumi K; Fujimoto K; Sakai T; Kumano K; Obara M; Koike T
Eur J Haematol; 2005 Jun; 74(6):526-8. PubMed ID: 15876258
[TBL] [Abstract][Full Text] [Related]
7. Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature.
Narra K; Borghaei H; Al-Saleem T; Höglund M; Smith MR
Leuk Res; 2006 Jan; 30(1):109-14. PubMed ID: 16043218
[TBL] [Abstract][Full Text] [Related]
8. Successful therapy of chronic graft-versus-host disease manifesting as pure red cell aplasia with single-agent rituximab.
Benson DM; Smith MK; Krugh D; Devine SM
Bone Marrow Transplant; 2008 Mar; 41(6):595-6. PubMed ID: 18037934
[No Abstract] [Full Text] [Related]
9. T-cell/histiocyte-rich large B-cell lymphoma associated with a near-tetraploid karyotype and complex genetic abnormalities.
de Leval L; Harris NL; Lampertz S; Herens C
APMIS; 2006 Jun; 114(6):474-8. PubMed ID: 16856972
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of bone marrow findings in patients with angioimmunoblastic T-cell lymphoma.
Grogg KL; Morice WG; Macon WR
Br J Haematol; 2007 Jun; 137(5):416-22. PubMed ID: 17488486
[TBL] [Abstract][Full Text] [Related]
11. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
[TBL] [Abstract][Full Text] [Related]
12. Rituximab does not compromise the mobilization and engraftment of autologous peripheral blood stem cells in diffuse-large B-cell lymphoma.
Kamezaki K; Kikushige Y; Numata A; Miyamoto T; Takase K; Henzan H; Aoki K; Kato K; Nonami A; Kamimura T; Arima F; Takenaka K; Harada N; Fukuda T; Hayashi S; Ohno Y; Eto T; Harada M; Nagafuji K
Bone Marrow Transplant; 2007 May; 39(9):523-7. PubMed ID: 17369863
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia.
Maschan AA; Skorobogatova EV; Balashov DN; Pashanov ED; Trakhtman PE; Schipitzina IP; Skvortsova YV; Rumiantzev AG
Bone Marrow Transplant; 2002 Sep; 30(6):405-7. PubMed ID: 12235527
[TBL] [Abstract][Full Text] [Related]
14. T cell rich and histiocyte rich B cell lymphoma--a case report.
Rajwanshi A; Banerjee AK; Chawla YK
Indian J Pathol Microbiol; 1997 Jan; 40(1):85-9. PubMed ID: 9145621
[TBL] [Abstract][Full Text] [Related]
15. Successful autologous peripheral blood stem cell transplantation with rituximab administration for pediatric diffuse large B-cell lymphoma.
Imamura T; Yoshihara T; Morimoto A; Ishida H; Sugimoto T; Imashuku S
Pediatr Hematol Oncol; 2006; 23(1):19-24. PubMed ID: 16326408
[TBL] [Abstract][Full Text] [Related]
16. T-cell/histiocyte-rich B-cell lymphoma: biology, diagnosis, and management.
Abramson JS
Oncologist; 2006 Apr; 11(4):384-92. PubMed ID: 16614234
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune thrombocytopenia with clonal expansion of CD8-positive T cells after autologous peripheral blood stem cell transplantation for diffuse large B-cell lymphoma.
Isobe T; Tanimoto TE; Nakaji G; Miyamoto T; Yamasaki S; Takase K; Numata A; Fukuda T; Nagafuji K; Inaba S; Harada M
Bone Marrow Transplant; 2005 Feb; 35(3):315-6. PubMed ID: 15568035
[No Abstract] [Full Text] [Related]
18. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
[TBL] [Abstract][Full Text] [Related]
19. [Remission of lymphoma-associated pure red cell aplasia after successful chemotherapy for B-cell lymphoma].
Sakane E; Tsunemine H; Akasaka H; Ito K; Kodaka T; Takahashi Y; Takahashi T
Rinsho Ketsueki; 2012 Dec; 53(12):2021-4. PubMed ID: 23318970
[TBL] [Abstract][Full Text] [Related]
20. Rituximab for pure red cell aplasia after ABO-mismatched allogeneic peripheral blood progenitor cell transplantation.
Sorà F; De Matteis S; Piccirillo N; Chiusolo P; Laurenti L; Putzulu R; Leone G; Sica S
Transfusion; 2005 Apr; 45(4):643-5. PubMed ID: 15819690
[No Abstract] [Full Text] [Related]
[Next] [New Search]
